Novel therapeutic agents for the treatment of myelodysplastic syndromes

被引：0
作者：
Cheson, BD [1 ]
Zwiebel, JA [1 ]
Dancey, J [1 ]
Murgo, A [1 ]
机构：
[1] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：560 / 577
页数：18
相关论文
共 195 条
[1]  
AHERNE GW, CANC CHEMOTHER PHARM, V38, P225
[2]   ENHANCEMENT OF ANTITUMOR-ACTIVITY OF MITOMYCIN-C INVITRO AND INVIVO BY UCN-01, A SELECTIVE INHIBITOR OF PROTEIN-KINASE-C [J].
AKINAGA, S ;
NOMURA, K ;
GOMI, K ;
OKABE, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (03) :183-189
[3]  
Akiyama T, 1997, CANCER RES, V57, P1495
[4]  
ANDREEFF M, 1992, BLOOD, V80, P2604
[5]   DIFFERENTIATION OF MYELOID LEUKEMIC-CELLS - NEW POSSIBILITIES FOR THERAPY [J].
BACCARANI, M ;
TURA, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 42 (03) :485-487
[6]   LOW-DOSE ARABINOSYL CYTOSINE FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES AND SUBACUTE MYELOID-LEUKEMIA [J].
BACCARANI, M ;
ZACCARIA, A ;
BANDINI, G ;
CAVAZZINI, G ;
FANIN, R ;
TURA, S .
LEUKEMIA RESEARCH, 1983, 7 (04) :539-545
[7]   DIFFERENTIAL-EFFECTS OF ACTIVE ISOMERS, SEGMENTS, AND ANALOGS OF DOLASTATIN-10 ON LIGAND INTERACTIONS WITH TUBULIN - CORRELATION WITH CYTOTOXICITY [J].
BAI, R ;
ROACH, MC ;
JAYARAM, SK ;
BARKOCZY, J ;
PETTIT, GR ;
LUDUENA, RF ;
HAMEL, E .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (07) :1503-1515
[8]  
BAI R, 1990, J BIOL CHEM, V265, P17141
[9]   DOLASTATIN-10, A POWERFUL CYTOSTATIC PEPTIDE DERIVED FROM A MARINE ANIMAL - INHIBITION OF TUBULIN POLYMERIZATION MEDIATED THROUGH THE VINCA ALKALOID BINDING DOMAIN [J].
BAI, R ;
PETTIT, GR ;
HAMEL, E .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) :1941-1949
[10]  
Barrett AJ, 1998, BLOOD, V92, p713A
12345678910